![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 239/42 | (2006.01) |
C07D 239/84 | (2006.01) | ||
C07D 471/04 | (2006.01) | ||
C07D 475/00 | (2006.01) | ||
C07D 487/04 | (2006.01) | ||
A61K 31/437 | (2006.01) | ||
A61K 31/505 | (2006.01) | ||
A61K 31/506 | (2006.01) | ||
A61K 31/517 | (2006.01) | ||
A61K 31/519 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2872491 |
(13) | Kind of document | T |
(96) | European patent application number | 13740458.8 |
Date of filing the European patent application | 2013-07-11 | |
(97) | Date of publication of the European application | 2015-05-20 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
(46) | Date of publication of the claims translation | 2021-08-25 |
(86) | Number | PCT/US2013/050106 |
Date | 2013-07-11 |
(87) | Number | WO 2014/011900 |
Date | 2014-01-16 |
(30) | Number | Date | Country code |
201261670379 P | 2012-07-11 | US | |
201261746666 P | 2012-12-28 | US |
(72) |
BIFULCO, Neil, Jr., US
BROOIJMANS, Natasja, US
HODOUS, Brian, L., US
KIM, Joseph, L., US
MIDUTURU, Chandrasekhar, V., US
WENGLOWSKY, Steven Mark, US
|
(73) |
Blueprint Medicines Corporation,
45 Sidney Street, Cambridge, MA 02139,
US
|
(74) |
Vitalija BANAITIENÄ–,
UAB TARPINÄ–, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
(54) | Fibroblasto augimo faktoriaus receptoriaus inhibitoriai |
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR |
Payment date | Validity (years) | Amount | |
2025-06-18 | 13 | 289.00 EUR |
2026-07-11 |